Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Endomagnetics Selected as Future Star

Abstract:
Endomagnetics, the company developing a portfolio of products to improve the standard of breast cancer management, has been selected as one of the UK's most exciting, high-potential new businesses by the Real Business Future 50 project.

Endomagnetics Selected as Future Star

Cambridge, UK | Posted on November 16th, 2012

The Future 50 companies were unveiled at a ceremony at the British Library Conference Centre in London last night, organized by Real Business in conjunction with Wonga.com. The programme was launched in 2011, and identifies, celebrates and supports young companies that are triggering change in their markets, or creating new markets.



Endomagnetics was founded by Simon Hattersley, Audrius Brazdeikis and Quentin Pankhurst to develop nanomagnetic technology as an alternative to the radioisotopes currently used for tracking the spread of cancer. By avoiding the problems of short lifetimes and specialist handling of radioactive alternatives, as many as a quarter of a million more breast cancer patients in the West could benefit from the ‘standard of care' SLNB procedure. With a special nanomagnetic system consisting of the SentiMag® instrument and associated Sienna+® tracer, clinicians have available a lower cost, more patient-friendly alternative that greatly improves workflow.



Dr Eric Mayes, CEO of Endomagnetics was asked to give a short presentation to the invited audience. In this he said: "We are naturally delighted to have been selected by this important programme. Since the spin-out from UCL in 2007, we have been well-backed by our investors and have just completed a 160-patient equivalence trial at seven sites in the UK and The Netherlands."



Matthew Rock, part of the founding team of Real Business, said: "Partnering with Wonga, the British Library Business & IP Centre and our panel of expert judges, we've spent six months investigating businesses across the country to select just 50 that we think will be 'challenger' businesses of the future. What's so impressive is to see young firms challenging established industries with a new, often digital, vision. The Wonga Future 50, published with Real Business, illustrates the dynamic change coursing through our economy."



Errol Damelin, Wonga co-founder and CEO, said: "We decided to create the Wonga Future 50, together with Real Business, to help identify, celebrate and, critically, support the most exciting early-stage UK businesses that are launching new products and services to trigger change. We congratulate all 50 businesses on their vision and ambition."



In August, Endomagnetics announced that it had been awarded government funding to explore the clinical feasibility of applying magnetic sentinel lymph node (SLN) detection to melanoma, a significant cancer with more than 116,000 cases per year in the EU and US alone.

####

About Endomagnetics
Endomagnetics was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. Endomagnetics is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston.

The company’s first product, the SentiMag®, is an ultrasensitive hand-held probe for tracking injected Sienna+™ nanoscale magnetic materials in the human body. Cambridge, UK-based Endomagnetics is in the process of delivering its technology to global markets. For more information please visit www.endomagnetics.com.

About Real Business

Real Business was the UK’s first magazine focused on entrepreneurs and growing businesses. Today Real Business runs a portfolio of events and publishing projects focused on the UK’s most dynamic growth businesses.

About Wonga.com

Wonga is a ground-breaking digital finance company based in London. Since 2007 when the company launched its first website, wonga.com, it has gone on to make more than six million loans via the web and mobile. The company’s products are designed to solve customers’ occasional cash flow problems in a short-term and completely responsible way.

The company recently launched its new platform www.openwonga.com to engage in conversations on the internet (social media, blogs, media articles etc.) and to inform the debate surrounding the business.

Wonga is backed by some of the world’s most respected investors including Accel Partners, Greylock Partners, Balderton Capital, Oak Investment Partners, Dawn Capital, Meritech and the Wellcome Trust.

For more information, please click here

Contacts:
Editorial contact:
Terry Nicklin

KeynotePR Ltd
Tel: +44 (0)7923 540695


Company contact:
Dr Eric Mayes
CEO
Endomagnetics Ltd
Tel: +44 (0)1223 437131

Copyright © Endomagnetics

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Renishaw receives Queen's Award for spectroscopy developments November 25th, 2014

JPK reports on the use of AFM and the CellHesion module to study plant cells at the University of Queensland November 25th, 2014

Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014

Research yields material made of single-atom layers that snap together like Legos November 25th, 2014

Nanomedicine

Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014

Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014

ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014

An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014

Announcements

Renishaw receives Queen's Award for spectroscopy developments November 25th, 2014

JPK reports on the use of AFM and the CellHesion module to study plant cells at the University of Queensland November 25th, 2014

Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014

Research yields material made of single-atom layers that snap together like Legos November 25th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Renishaw receives Queen's Award for spectroscopy developments November 25th, 2014

A*STAR SIMTech wins international award for breaking new ground in actuators: SIMTech invention can be used in an array of industries, and is critical for next generation ultra-precision systems November 24th, 2014

SUNY Poly Student Awarded Fellowship with the U.S. Department of Energy's Postgraduate Research Program: Ph.D. Candidate Accepts Postmaster's Appointment To Conduct Research At Albany NanoTech Complex November 13th, 2014

MEMS Industry Group's 10th Annual Executive Conference Showcases Rapid Innovation in MEMS/Sensors: Emphasizes Spirit of Collaboration, Supporting First Open-Source Algorithm Community, New Standardization Efforts November 10th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE